Cargando…
Plectin in Cancer: From Biomarker to Therapeutic Target
The cytolinker and scaffolding protein, plectin, has emerged as a potent driver of malignant hallmarks in many human cancers due to its involvement in various cellular activities contributing to tumorigenesis, including cancer cell proliferation, adhesion, migration, invasion, and signal transductio...
Autores principales: | Perez, Samantha M., Brinton, Lindsey T., Kelly, Kimberly A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469460/ https://www.ncbi.nlm.nih.gov/pubmed/34571895 http://dx.doi.org/10.3390/cells10092246 |
Ejemplares similares
-
A Novel Monoclonal Antibody Targeting Cancer-Specific Plectin Has Potent Antitumor Activity in Ovarian Cancer
por: Perez, Samantha M., et al.
Publicado: (2021) -
Plectin-targeted liposomes enhance the therapeutic efficacy of a PARP inhibitor in the treatment of ovarian cancer
por: Dasa, Siva Sai Krishna, et al.
Publicado: (2018) -
Plectin-1 Targeted AAV Vector for the Molecular Imaging of Pancreatic Cancer
por: Konkalmatt, Prasad R., et al.
Publicado: (2013) -
Plectin in Skin Fragility Disorders
por: Kiritsi, Dimitra, et al.
Publicado: (2021) -
Plectin in Health and Disease
por: Wiche, Gerhard
Publicado: (2022)